vs
Side-by-side financial comparison of Claros Mortgage Trust, Inc. (CMTG) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $46.7M, roughly 1.3× Claros Mortgage Trust, Inc.). Cytek Biosciences, Inc. runs the higher net margin — -70.9% vs -468.9%, a 398.0% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -22.4%). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -10.9%).
Claros Mortgage Trust, Inc. is a U.S.-based real estate investment trust that invests in diversified mortgage-related assets, including residential and commercial mortgage loans and mortgage-backed securities. It pursues stable, risk-adjusted long-term returns for shareholders via rigorous asset evaluation and active portfolio management.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
CMTG vs CTKB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $46.7M | $62.1M |
| Net Profit | $-219.2M | $-44.1M |
| Gross Margin | — | 52.9% |
| Operating Margin | — | -9.0% |
| Net Margin | -468.9% | -70.9% |
| Revenue YoY | -22.4% | 8.1% |
| Net Profit YoY | -117.7% | -557.1% |
| EPS (diluted) | $-1.56 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $46.7M | $62.1M | ||
| Q3 25 | $46.1M | $52.3M | ||
| Q2 25 | $51.6M | $45.6M | ||
| Q1 25 | $43.4M | $41.5M | ||
| Q4 24 | $60.2M | $57.5M | ||
| Q3 24 | $64.9M | $51.5M | ||
| Q2 24 | $64.5M | $46.6M | ||
| Q1 24 | $58.8M | $44.9M |
| Q4 25 | $-219.2M | $-44.1M | ||
| Q3 25 | $-9.5M | $-5.5M | ||
| Q2 25 | $-181.7M | $-5.6M | ||
| Q1 25 | $-78.6M | $-11.4M | ||
| Q4 24 | $-100.7M | $9.6M | ||
| Q3 24 | $-56.2M | $941.0K | ||
| Q2 24 | $-11.6M | $-10.4M | ||
| Q1 24 | $-52.8M | $-6.2M |
| Q4 25 | — | 52.9% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 54.6% | ||
| Q1 24 | — | 51.3% |
| Q4 25 | — | -9.0% | ||
| Q3 25 | — | -17.6% | ||
| Q2 25 | — | -23.3% | ||
| Q1 25 | — | -36.1% | ||
| Q4 24 | — | 5.2% | ||
| Q3 24 | — | -8.2% | ||
| Q2 24 | — | -18.3% | ||
| Q1 24 | — | -23.9% |
| Q4 25 | -468.9% | -70.9% | ||
| Q3 25 | -20.7% | -10.5% | ||
| Q2 25 | -351.9% | -12.2% | ||
| Q1 25 | -181.3% | -27.5% | ||
| Q4 24 | -167.2% | 16.8% | ||
| Q3 24 | -86.7% | 1.8% | ||
| Q2 24 | -17.9% | -22.4% | ||
| Q1 24 | -89.7% | -13.8% |
| Q4 25 | $-1.56 | — | ||
| Q3 25 | $-0.07 | — | ||
| Q2 25 | $-1.30 | — | ||
| Q1 25 | $-0.56 | — | ||
| Q4 24 | $-0.72 | — | ||
| Q3 24 | $-0.40 | — | ||
| Q2 24 | $-0.09 | — | ||
| Q1 24 | $-0.39 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $173.2M | $90.9M |
| Total DebtLower is stronger | $3.2B | — |
| Stockholders' EquityBook value | $1.5B | $341.7M |
| Total Assets | $4.7B | $461.5M |
| Debt / EquityLower = less leverage | 2.06× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $173.2M | $90.9M | ||
| Q3 25 | $339.5M | $93.3M | ||
| Q2 25 | $209.2M | $75.5M | ||
| Q1 25 | $127.8M | $95.3M | ||
| Q4 24 | $99.1M | $98.7M | ||
| Q3 24 | $113.9M | $162.3M | ||
| Q2 24 | $148.2M | $177.9M | ||
| Q1 24 | $232.5M | $168.8M |
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.7B | — | ||
| Q2 25 | $4.0B | — | ||
| Q1 25 | $4.7B | — | ||
| Q4 24 | $4.9B | — | ||
| Q3 24 | $5.1B | — | ||
| Q2 24 | $5.3B | — | ||
| Q1 24 | $5.5B | — |
| Q4 25 | $1.5B | $341.7M | ||
| Q3 25 | $1.7B | $378.6M | ||
| Q2 25 | $1.8B | $377.6M | ||
| Q1 25 | $1.9B | $379.6M | ||
| Q4 24 | $2.0B | $395.7M | ||
| Q3 24 | $2.1B | $385.5M | ||
| Q2 24 | $2.2B | $389.1M | ||
| Q1 24 | $2.2B | $392.6M |
| Q4 25 | $4.7B | $461.5M | ||
| Q3 25 | $5.4B | $494.9M | ||
| Q2 25 | $5.8B | $493.3M | ||
| Q1 25 | $6.7B | $482.6M | ||
| Q4 24 | $7.0B | $499.5M | ||
| Q3 24 | $7.3B | $491.2M | ||
| Q2 24 | $7.6B | $483.7M | ||
| Q1 24 | $7.8B | $492.1M |
| Q4 25 | 2.06× | — | ||
| Q3 25 | 2.09× | — | ||
| Q2 25 | 2.29× | — | ||
| Q1 25 | 2.42× | — | ||
| Q4 24 | 2.44× | — | ||
| Q3 24 | 2.44× | — | ||
| Q2 24 | 2.46× | — | ||
| Q1 24 | 2.47× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-30.5M | $-771.0K |
| Free Cash FlowOCF − Capex | — | $-1.8M |
| FCF MarginFCF / Revenue | — | -2.9% |
| Capex IntensityCapex / Revenue | — | 1.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-30.5M | $-771.0K | ||
| Q3 25 | $8.8M | $-3.9M | ||
| Q2 25 | $-5.8M | $108.0K | ||
| Q1 25 | $-35.8M | $-125.0K | ||
| Q4 24 | $84.5M | $2.0M | ||
| Q3 24 | $39.2M | $13.2M | ||
| Q2 24 | $5.5M | $6.2M | ||
| Q1 24 | $21.5M | $4.0M |
| Q4 25 | — | $-1.8M | ||
| Q3 25 | — | $-4.6M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-974.0K | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | — | $12.2M | ||
| Q2 24 | — | $5.2M | ||
| Q1 24 | — | $3.4M |
| Q4 25 | — | -2.9% | ||
| Q3 25 | — | -8.7% | ||
| Q2 25 | — | -3.2% | ||
| Q1 25 | — | -2.3% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 23.7% | ||
| Q2 24 | — | 11.0% | ||
| Q1 24 | — | 7.6% |
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.0% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | 1.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | — | 14.05× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMTG
| Real Estate Owned Portfolio | $34.2M | 73% |
| Other | $11.1M | 24% |
| Mixed Use Property Fixed Rents | $1.4M | 3% |
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
